Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson’s Disease Conference

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson’s Disease Conference
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, ... read more
Source: Bing NewsPublished on 2022-09-21